Tech Company Inital Public Offerings
Genocea Biosciences IPO
Genocea Biosciences, operating out of Cambridge, debuted as a public company on 2/5/2014.
Transaction Overview
Company Name
Announced On
2/5/2014
Transaction Type
IPO
Amount
$66,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chip Clark
Chief Financial Officer
Diantha Duvall
Chief Medical Officer
Thomas Davis
Chief Scientific Officer
Jessica Flechtner
VP - Bus. Development
Girish Aakalu
VP - Manufacturing
Narinder Singh
Browse more venture capital transactions:
Prev: 2/5/2014: Apportable venture capital transaction
Next: 2/5/2014: Selectica venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs